Učitavanje...

A bivalent ligand (KMN-21) antagonist for μ/κ heterodimeric opioid receptors

In an effort to develop antagonists for κ-μ opioid receptor heterodimers, a series of bivalent ligands 3 - 6 containing κ- and μ-antagonist pharmacophores were designed and synthesized. Evaluation of the series in HEK-293 cells revealed 4 (KMN-21) to selectively antagonize the activation of κ-μ hete...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Bioorg Med Chem Lett
Glavni autori: Zhang, Shijun, Yekkirala, Ajay, Tang, Ye, Portoghese, Philip S.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5060004/
https://ncbi.nlm.nih.gov/pubmed/19892550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2009.10.045
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!